tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoffrey Porges, 192 are a BUY (67.13%), 93 are a HOLD (32.52%), 1 are a SELL (0.35%).
Analyst Geoffrey Porges, currently employed at LEERINK, carries an average stock price target met ratio of 58.35% that have a potential upside of 26.96% achieved within 372 days. Previously, Geoffrey Porges worked at BERNSTEIN.
Geoffrey Porges’s has documented 591 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive sectors.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 02-Mar-2026.
Analyst best performing recommendations are on DOVA (DOVA PHARMACEUTICALS).
The best stock recommendation documented was for EPZM (EPIZYME) at 6/19/2020. The price target of $16 was fulfilled within 7 days with a profit of $2.84 (15.07%) receiving and performance score of 21.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$52.18 (19.85%)
$265
24 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$40.18 (15.29%)
$298
1 months 14 days ago
(20-Aug-2026)
2/11 (18.18%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$37.18 (14.15%)
$295
1 months 17 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$37.18 (14.15%)
1 months 21 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-2.82 (-1.07%)
$235
1 months 24 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
What Year was the first public recommendation made by Geoffrey Porges?
